Nuzenio

Cybin

Cybin news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 15 latest news signals 13 publisher sources 100/100 entity strength

Latest news

Helus Pharma's Rally Puts Phase-3 Data in the Spotlight as New CEO Takes the Helm - AD HOC NEWSAD HOC NEWS · Sun, 09 Aug 2026 04:22:03 GMTCertain Common Shares of Cybin Inc. are subject to a Lock-Up Agreement Ending on 9-AUG-2026. - marketscreener.commarketscreener.com · Sun, 09 Aug 2026 00:38:55 GMTTop Cybin (HELP) Competitors 2026 - MarketBeatMarketBeat · Sat, 08 Aug 2026 20:02:28 GMTCybin (HELP) Names New CEO, Is The Stock Still Cheap? - Yahoo! Finance CanadaYahoo! Finance Canada · Sat, 08 Aug 2026 18:10:30 GMTCybin D/B/A Helus Pharma (HELP) stock price, news, quote and history - Yahoo Finance UKYahoo Finance UK · Fri, 07 Aug 2026 23:15:50 GMTCybin Inc (CN:HELP) Rallies 4.62%: rebranded psychedelic-medicine developer is trading briskly after a new CEO and an ahead-of-schedule Phase 3 enrollment, - kalkine.cakalkine.ca · Fri, 07 Aug 2026 10:36:00 GMTCybin (HELP) Is Up 33.1% After Hiring Helus Veteran Michael Halstead As CEO – Has The Bull Case Changed? - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 14:18:09 GMTCybin (Helus Pharma, HELP) Leaps 14% Ahead of Pivotal Depression Trial Data - kalkine.cakalkine.ca · Thu, 06 Aug 2026 12:56:00 GMT

Timeline

Sun, 09 Aug 2026 04:22:03 GMTHelus Pharma's Rally Puts Phase-3 Data in the Spotlight as New CEO Takes the Helm - AD HOC NEWS
Sun, 09 Aug 2026 00:38:55 GMTCertain Common Shares of Cybin Inc. are subject to a Lock-Up Agreement Ending on 9-AUG-2026. - marketscreener.com
Sat, 08 Aug 2026 20:02:28 GMTTop Cybin (HELP) Competitors 2026 - MarketBeat
Sat, 08 Aug 2026 18:10:30 GMTCybin (HELP) Names New CEO, Is The Stock Still Cheap? - Yahoo! Finance Canada
Fri, 07 Aug 2026 23:15:50 GMTCybin D/B/A Helus Pharma (HELP) stock price, news, quote and history - Yahoo Finance UK
Fri, 07 Aug 2026 10:36:00 GMTCybin Inc (CN:HELP) Rallies 4.62%: rebranded psychedelic-medicine developer is trading briskly after a new CEO and an ahead-of-schedule Phase 3 enrollment, - kalkine.ca

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Cybin.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

13 distinct publisher/source names are currently connected to this entity page.